This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Is It Worth Investing in Affirm Holdings (AFRM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Affirm Holdings (AFRM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AFRMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Shopify (SHOP) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Shopify (SHOP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SHOPPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Energy Fuels (UUUU): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Energy Fuels (UUUU) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
UUUUNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in CRISPR Therapeutics (CRSP) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for CRISPR Therapeutics (CRSP) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CRSPPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Ardmore Shipping (ASC): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Ardmore Shipping (ASC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ASCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Leidos (LDOS) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Leidos (LDOS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
LDOSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
AudioEye (AEYE) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for AudioEye (AEYE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AEYENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Interactive Brokers (IBKR): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Interactive Brokers (IBKR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
IBKRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Cipher Mining (CIFR): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Cipher Mining (CIFR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CIFRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is BigBear.ai (BBAI) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), BigBear.ai (BBAI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BBAINegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Fiverr (FVRR) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Fiverr (FVRR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
FVRRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Celestica (CLS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Celestica (CLS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CLSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Howmet (HWM) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Howmet (HWM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
HWMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
UNHNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in RTX (RTX): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for RTX (RTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
RTXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in HCI Group (HCI): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in HCI Group (HCI). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
HCIPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Star Bulk Carriers (SBLK) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Star Bulk Carriers (SBLK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SBLKNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Okta (OKTA): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Okta (OKTA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
OKTANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in CrowdStrike (CRWD) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CrowdStrike (CRWD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CRWDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Vital Farms (VITL) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Vital Farms (VITL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
VITLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Wix.com (WIX) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Wix.com (WIX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
WIXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Duolingo (DUOL): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Duolingo (DUOL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
DUOLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Dutch Bros (BROS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Dutch Bros (BROS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BROSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About New Gold (NGD): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for New Gold (NGD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NGDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Boston Scientific (BSX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
BSXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth